Statutory instrument on genetically modified organisms

Amends existing legislation to ensure consents to market genetically modified organisms authorised at the EU-level remain valid after Brexit, continue with authorisation process for release or marketing of organisms in each of the home nations and to enable the UK to enforce its obligations under the Cartagena Biosafety Protocol